effects of glp-1 receptor agonists on neurological complications of diabetes | Reviews in Endocrine and Metabolic Disorders An analysis on the role
Description
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.
This acquisition is aimed at enhancing its portfolio with the addition of Metsera's Next-Generation Obesity Portfolio.
Its a peptide
Records were reviewed for patient characteristics and medication type and doses
Explore GLP-1 trends as users foresee long-term use and increased spending on clothing, groceries, and more
